Opportunity ID: 337196

General Information

Document Type: Grants Notice
Funding Opportunity Number: RFA-CA-22-007
Funding Opportunity Title: Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (U54 Clinical Trials Optional)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Category of Funding Activity: Education
Health
Category Explanation:
Expected Number of Awards:
Assistance Listings: 93.394 — Cancer Detection and Diagnosis Research
Cost Sharing or Matching Requirement: No
Version: Synopsis 1
Posted Date: Jan 04, 2022
Last Updated Date: Jan 04, 2022
Original Closing Date for Applications: Sep 22, 2022
Current Closing Date for Applications: Sep 22, 2022
Archive Date: Oct 28, 2022
Estimated Total Program Funding:
Award Ceiling: $150,000
Award Floor:

Eligibility

Eligible Applicants: Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
County governments
Independent school districts
State governments
Private institutions of higher education
Native American tribal organizations (other than Federally recognized tribal governments)
For profit organizations other than small businesses
Small businesses
Public housing authorities/Indian housing authorities
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Special district governments
Others (see text field entitled “Additional Information on Eligibility” for clarification)
Public and State controlled institutions of higher education
City or township governments
Native American tribal governments (Federally recognized)
Additional Information on Eligibility: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.

Additional Information

Agency Name: National Institutes of Health
Description: The purpose of this Funding Opportunity Announcement (FOA) is to encourage revision applications (formerly called “competing revisions”) from currently funded NCI U54 Resource-Related Research Projects proposing to expand upon original research question(s) from specific projects or otherwise accelerate progress for the parent study by incorporating a new technical approach or instrument developed through support from the NCI Innovative Molecular Analysis Technologies (IMAT) program. Awards from this FOA are meant to incentivize independent validation and accelerate the suitability of these emerging technologies for appropriate research communities. As a component of the NCI IMAT program, this FOA aims to promote interdisciplinary collaboration in the development of innovative tools and methods that enable cancer research and accelerate scientific discovery.
Link to Additional Information: http://grants.nih.gov/grants/guide/rfa-files/RFA-CA-22-007.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH OER Webmaster
OERWebmaster03@od.nih.gov
Email:OERWebmaster03@od.nih.gov

Version History

Version Modification Description Updated Date

Folder 337196 Full Announcement-RFA-CA-22-007 -> RFA-CA-22-007-Full-Announcement.pdf

Packages

Agency Contact Information: NIH OER Webmaster
OERWebmaster03@od.nih.gov
Email: OERWebmaster03@od.nih.gov
Who Can Apply: Organization Applicants

Assistance Listing Number Competition ID Competition Title Opportunity Package ID Opening Date Closing Date Actions
FORMS-G Use for due dates on or after January 25, 2022 PKG00271197 Mar 22, 2022 Sep 22, 2022 View

Package 1

Mandatory forms

337196 RR_SF424_5_0-5.0.pdf

337196 PHS398_CoverPageSupplement_5_0-5.0.pdf

337196 RR_OtherProjectInfo_1_4-1.4.pdf

337196 PerformanceSite_4_0-4.0.pdf

337196 RR_KeyPersonExpanded_4_0-4.0.pdf

337196 PHS398_ResearchPlan_4_0-4.0.pdf

337196 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf

Optional forms

337196 PHS_Additional_IndirectCosts_2_0-2.0.pdf

337196 PHS_AssignmentRequestForm_3_0-3.0.pdf

2025-07-12T08:57:00-05:00

Share This Post, Choose Your Platform!

About the Author: